Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Marseille Cedex 5, France Clinical Trials

A listing of Marseille Cedex 5, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (129) clinical trials

UNiD Rods Register

Despite decades of treatment and great diversity of instrumentation, the objective of sagittal spinal realignment in adult spinal deformity is achieved in only 38% of patients which reflects an inadequacy of the approach currently used. Patient specific rods were created by Medicrea to address this gap and support surgeons in ...

Phase N/A

0.0 miles

Learn More »

PASS MIS Post-market Clinical Follow-up

Patients operated with PASS MIS manufactured by MEDICREA INTERNATIONAL between July 2016 and July 2017. The inclusion period will be 12 months and the follow-up 24 months

Phase N/A

0.0 miles

Learn More »

PASS OCT Post-market Clinical Follow-up

The primary endpoint is to evaluate the safety of the PASS OCT system. The secondary endpoints are to analyze the efficacy of the system with several point of view: The quality of fusion and the time of fusion through X rays the pain with VAS the quality of life thanks ...

Phase N/A

0.0 miles

Learn More »

French Registry of First-line Treatment of Acute Promyelocytic Leukemia

Collection of epidemiological data on non-high-risk APL patients aged 70 years: age and sex distribution, medical history, prognostic factors (time to treatment start, severity of coagulopathy at presentation, Performance status). Documentation of clinical and biologic effectiveness of the two first-line treatment approaches available for non-high-risk APL patients. Documentation of Minimal ...

Phase N/A

0.0 miles

Learn More »

Characterization of Anti-FGFR3 Antibodies

In and out patients evaluated for a sensory neuropathy meeting the inclusion and non-inclusion criteria will be proposed to enter the study At inclusion the SSN diagnostic score is calculated and a blood sample is tested for anti-FGFR3 antibody. Follow up: Patients positive for anti-FGFR3 antibodies will be followed and ...

Phase N/A

0.0 miles

Learn More »

Phase N/A

0.0 miles

Learn More »

Early Diagnosis of TTR Amyloidosis by Use of Molecular Biology

Study of the TTR gene by complete sequencing; search for amyloidogenic mutations of the TTR gene (according to the site http: // amyloidosismutations.com / mut-attr.php) in the laboratory of molecular biology of the CHU BICTRE (APHP) managed by Pr Anne Mantel. Preselection of the cases to be tested among the ...

Phase N/A

0.0 miles

Learn More »

Post-ATU Study of Nivolumab

In order to reach goals of this study, collaboration had been established between BMS and the RIC-Mel network (network for Research and Clinical Investigational Research on Melanoma) (NCT03315468). The RIC-Mel network has set up a national database in order to reference the active file of melanoma patients in France. The ...

Phase N/A

0.0 miles

Learn More »

Multi-scale Analysis of Physiological Brain Networks

Brain function is based on the communication between sets of neurons at different spatial and temporal scales. The dysfunction of these networks is thus at the origin of several brain pathologies, including epilepsy. The recent improvement in recording methods paves the way for better characterization of brain networks, with several ...

Phase N/A

0.0 miles

Learn More »

CYSTEA-BONE Clinical Study

Nephropathic Cystinosis (NC) is an orphan inherited autosomal recessive disease characterised as a generalized lysosomal storage disease due to a deficiency of the cystine lysosomal transport protein, cystinosin. Patients with NC usually receive cysteamine. Bone impairment was recently recognized as a late complication of NC, occurring at adolescence or early ...

Phase N/A

0.0 miles

Learn More »